Verge

Verge Genomics is a biotechnology company using an AI‑enabled, all‑in‑human discovery platform to identify drug targets and candidates directly from human data.

The company is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinson’s disease.